Rabbit Polyclonal RIP3 antibody. Suitable for IP, WB and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Synthetic Peptide within Human RIPK3 aa 400-450.
View Alternative Names
RIP3, RIPK3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3
- IP
Supplier Data
Immunoprecipitation - Anti-RIP3 antibody (AB226297)
RIP3 was immunoprecipitated from Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate (prepared using RIPA buffer; 1 mg for IP, 20% of IP loaded) with ab226297 at 6 μg per reaction. Western blot was performed from the immunoprecipitate using ab226297 at 1 μg/ml.
Lane 1 : ab226297 IP in Jurkat whole cell lysate.
Lane 2 : Control IgG IP in Jurkat whole cell lysate.
Detection : Chemiluminescence with exposure time of 30 seconds.
All lanes:
Immunoprecipitation - Anti-RIP3 antibody (ab226297)
Predicted band size: 57 kDa
false
- WB
Supplier Data
Western blot - Anti-RIP3 antibody (AB226297)
All lanes:
Western blot - Anti-RIP3 antibody (ab226297) at 0.4 µg/mL
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate prepared using NETN buffer at 50 µg
Lane 2:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate prepared using NETN buffer at 50 µg
Lane 3:
Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate prepared using NETN buffer at 50 µg
Lane 4:
Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate prepared using RIPA buffer at 50 µg
Predicted band size: 57 kDa
true
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.
Pathways
RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
The EMBO journal 44:3231-3265 PubMed40240880
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 8:4 PubMed39753884
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 43:1955-1971 PubMed38730267
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 31:631-643 PubMed37547755
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of medical sciences 20:870-887 PubMed37324188
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ophthalmology 2022:2285663 PubMed36457949
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:451 PubMed36344541
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:1041117 PubMed36408256
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:9325973 PubMed35965682
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com